Effectiveness of a Mobile App for Individuals With or at Risk of Knee Osteoarthritis

November 5, 2020 updated by: Dr. Calvin Or, The University of Hong Kong

Effectiveness of an Interactive, Multi-functional Mobile App-based Technology in Endogenous Healthcare for Individuals With or at Risk of Knee Osteoarthritis: A 12-month Randomized Controlled Trial

To develop and examine an interactive, multi-functional mobile app-based technology designed to encourage endogenous health care using a 12-month randomized controlled trial to demonstrate whether knee osteoarthritis (KOA)-at-risk individuals and KOA-diagnosed patients can improve their knee pain, physical function, and other relevant outcomes by using the technology to support knee/KOA self-management.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Knee osteoarthritis (KOA), the most common degenerative condition affecting the peripheral weight-bearing joints, leads to pain, restricted mobility, and financial and moral burden. These effects will increase with rising numbers of incidents, exacerbated by population aging and obesity. Zhang et al. found KOA in 43% and 22% (15% and 6% in symptomatic individuals) of Chinese women and men, respectively, 60 years or older. In the United States, KOA affects 12% of the elderly population, and it is projected that the need for total knee replacement (TKR) to treat end-stage KOA will grow by 673% to 3.48 million procedures a year from 2005 to 2030, with the demand for TKR revision doubling from 2005 to 2015. Hong Kong's public hospitals performed 6658 TKRs from 2011 to 2014, with 10,000 cases wait-listed for 2016. These figures suggest that KOA will impose significant and increasing pressure on Hong Kong's healthcare system.

As quadriceps muscle weakness increases the risk of KOA, its symptoms should be alleviated by leg muscle strengthening. Land-based exercise has been effective under close monitoring and supervision. A recent Cochrane Review involving 54 studies concluded that there is moderate to high-quality evidence that land-based exercises significantly improve muscle strength, physical function, and quality of life and reduce pain in KOA patients. The effect of such exercises is comparable to that of nonsteroidal anti-inflammatory drugs with no significant adverse effects. However, therapist-delivered exercise is costly and often impractical, especially in a public-health context, and Internet-delivered exercise regimes represent an alternative approach. In today's information technology (IT)-enabled environment, mobile apps are readily accessible to users of untethered devices (e.g., smartphones). The "any-where, any-time" mobile IT could be exploited to more effectively manage KOA by encouraging self-motivation to substitute for direct monitoring. This study will present "IT-centered endogenous healthcare" as a public policy to boost self-help in primary care and test its practicability and efficacy in KOA management in Hong Kong. The word "endogenous" suggests that self-motivation is a form of self-insurance in primary care. It is further suggested that demand-side incentives will be needed to induce individuals to incrementally allocate more resources (particularly time and effort) to incrementally self-insure health at the primary level.

On the supply side, IT-based healthcare products have been mainly designed for commercial considerations such as marketing and are insufficiently focused on function for purposes of public health and policy. We follow Liao-Cheung's approach to reify demand-side incentives in the form of a publicly funded (and hence free) mobile app, the adoption of which could encourage self-insurance among individuals with knee problems or KOA. The users' time and effort will initially be rewarded by the app's user-friendliness and lack of a fee. The study's technology intervention, "mobile rehabilitation (mRehab) app", will link smartphones to videos of evidence-based, physiotherapist-prescribed exercises to alleviate knee/KOA symptoms, together with educational (e.g., diet and behavioral modifications) and motivational components. This mobile IT platform will have easier and wider accessibility than exercises delivered via tethered devices (e.g., desktop computers), and it can engage the users' interest whenever and wherever KOA effects are felt. Over time, self-motivation is also enhanced by high-frequency prompts, periodic upgrades with feedback, support from Internet KOA-awareness groups, the possibility of accumulating one's own health-data to facilitate queries and dialogue, and (most importantly) monitoring the health progression predicted by the exercise regimen.

A natural research sample follows in the form of IT-enabled individuals with knee/KOA problems. The proposed hypothesis is then offered that sustained use of the mRehab app will significantly reduce the symptoms and improve functions of individuals with quadriceps weakness and knee pain or KOA over time and compared to a sham app (the analytical control). The effectiveness of the mRehab app regarding this hypothesis will be tested in two samples: (1) KOA-at-risk individuals and (2) KOA-diagnosed patients, in a randomized controlled trial (RCT).

Study Type

Interventional

Enrollment (Anticipated)

320

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Hong Kong
      • Hong Kong, Hong Kong
        • Hong Kong East Cluster, Hospital Authority
        • Contact:
      • Hong Kong, Hong Kong
        • Hong Kong West Cluster, Hospital Authority
        • Contact:
      • Hong Kong, Hong Kong
        • New Territories East Cluster, Hospital Authority
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria for all participants:

  • at least 50 years of age,
  • a regular smartphone user,
  • able to speak Cantonese and read Chinese,
  • able to perform the exercises required in the physical assessments,
  • able to provide written informed consent.

Inclusion criteria for KOA-at-risk participants:

  • with subnormal quadriceps strength (as defined by the inability to complete five repetitions of a sit-to-stand test in less than 8 seconds [50 to 70 years of age], 10 seconds [70 to 79 years of age], or 12 seconds [80 years or older])
  • with significant chronic knee pain (i.e., ≥2/10 on the 11-point Numerical Pain Rating Scale for more than 3 months on most days of the previous month, aggravated by weight-bearing or movement)
  • without regular medical follow-up for knee problems

Inclusion criteria for KOA-diagnosed participants:

  • with symptomatic radiographic KOA and being followed-up in hospitals
  • have radiographic evidence of grade 2 to 3 KOA on the Kellgren-Lawrence scale in the posteroanterior and/or skyline view or the presence of lateral/posterior osteophytes.

Exclusion criteria:

  • have a cognitive impairment,
  • have nonambulatory status,
  • have systemic inflammatory arthritis (e.g., gout),
  • have a history of knee or hip replacement surgery,
  • have a history of trauma or surgical arthroscopy of either knee within the past 6 months,
  • involve in a similar study,
  • participate in a knee exercise program within the past 6 months,
  • have an intra-articular injection to the knee within the past 3 months,
  • have recent or imminent surgery (within 3 months),
  • have medical co-morbidities that preclude participation in exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: HEALTH_SERVICES_RESEARCH
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: mRehab app
Participants randomized to the intervention group will be given the mRehab app free of charge to perform self-management of their knees in their homes.
Device: mRehab app
The mRehab app will be an interactive system with a user-friendly graphical user interface to provide multiple motivational functions that engage individuals in their prescribed home exercises. The app will contain video-based lower limb strengthening and aerobic exercise materials, health information, and motivational functions to increase their access to rehabilitation and care resources to augment their self-management ability.
SHAM_COMPARATOR: Sham app
Participants randomized to the control group will receive a sham app free of charge to perform self-management of their knees in their homes.
Device: Sham app
The sham app will only contain educational components and text-based exercise recommendations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in knee pain
Time Frame: from baseline to 3, 6, 9, and 12 months
Knee pain will be assessed on a 11-point Numerical Pain Rating Scale, with 0 representing no pain and 10 representing the worst possible pain.
from baseline to 3, 6, 9, and 12 months
Changes in physical function of the knee
Time Frame: from baseline to 3, 6, 9, and 12 months
Physical function will be measured with the 17-item physical function for daily living subscale of the Knee Injury and Osteoarthritis Outcome Score (KOOS). A 5-point Likert scale is used and all items have five possible answer options scored from 0 (No Problems) to 4 (Extreme Problems).
from baseline to 3, 6, 9, and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in lower limb function
Time Frame: from baseline to 3, 6, 9, and 12 months
Lower limb function will be assessed by a 40-m fast-paced walking test, a 9-step stair-climb test, a five-repetition sit-to-stand test, active and passive ranges of motion of the hip and knee joints, and the mini-balance evaluation system test (mini-BESTest).
from baseline to 3, 6, 9, and 12 months
Changes in lower limb muscle strength
Time Frame: from baseline to 3, 6, 9, and 12 months
Maximal isometric strength of the quadriceps and hamstrings will be assessed by a handheld dynamometer.
from baseline to 3, 6, 9, and 12 months
Changes in health-related physical activity
Time Frame: from baseline to 3, 6, 9, and 12 months
Health-related physical activity will be assessed using the Chinese version of international physical activity questionnaire. This questionnaire asks participants to report the frequency and duration of walking, all vigorous and moderate activities lasting at least 10 min, plus time spent in sedentary activity (sitting and lying awake) during the past 7 days. The data were converted to metabolic equivalent scores for each type of activity, with higher score indicating more physical activity.
from baseline to 3, 6, 9, and 12 months
Changes in self-efficacy for coping with knee problems
Time Frame: from baseline to 3, 6, 9, and 12 months
Self-efficacy will be assessed using a 5-item self-efficacy scale modified from an existing validated scale, with scores ranging from 1 (not at all confident) to 10 (totally confident).
from baseline to 3, 6, 9, and 12 months
Changes in health-related quality of life
Time Frame: from baseline to 3, 6, 9, and 12 months
Health-related quality of life will be measured using the Chinese version of the EuroQoL 5-dimension 5-level (EQ-5D-5L) questionnaire, which consists of the EuroQoL 5-dimension (EQ-5D) descriptive system and the EQ visual analogue scale (VAS). The EQ-5D descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression; each dimension is rated on a 3-point scale (i.e., no problems, some problems, and extreme problems). The EQ VAS asks the subject to indicate his or her health state on a vertical, visual analog scale with end points of 0 (worst imaginable health state) and 100 (best imaginable health state).
from baseline to 3, 6, 9, and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

The University of Hong Kong

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

January 1, 2021

Primary Completion (ANTICIPATED)

March 31, 2023

Study Completion (ANTICIPATED)

March 31, 2023

Study Registration Dates

First Submitted

December 10, 2019

First Submitted That Met QC Criteria

December 12, 2019

First Posted (ACTUAL)

December 13, 2019

Study Record Updates

Last Update Posted (ACTUAL)

November 6, 2020

Last Update Submitted That Met QC Criteria

November 5, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HMRF 17181291

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Digital Health

Clinical Trials on mRehab app

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe